- Report
- October 2024
- 200 Pages
Global
From €3337EUR$3,750USD£2,885GBP
- Report
- October 2024
- 200 Pages
Global
From €3337EUR$3,750USD£2,885GBP
- Report
- May 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- May 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- May 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- March 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- March 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- March 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- March 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- March 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- January 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- January 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- January 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- January 2024
- 200 Pages
Global
From €3693EUR$4,150USD£3,193GBP
- Report
- July 2023
- 145 Pages
Global
From €2803EUR$3,150USD£2,424GBP
- Report
- February 2024
- 100 Pages
Global
From €4227EUR$4,750USD£3,655GBP
- Report
- April 2023
- 120 Pages
Global
From €4227EUR$4,750USD£3,655GBP
- Report
- January 2026
- 70 Pages
Indonesia
From €4227EUR$4,750USD£3,655GBP
- Report
- May 2025
- 70 Pages
Japan
From €4227EUR$4,750USD£3,655GBP
- Report
- July 2024
- 110 Pages
Global
From €4227EUR$4,750USD£3,655GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more